XML 31 R21.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Related Party Transactions
6 Months Ended
Jun. 30, 2011
RELATED PARTY TRANSACTION [Abstract]  
Related Party Transactions Disclosure [Text Block]
RELATED PARTY TRANSACTIONS
The table below presents the transactions between the Company and Watson.
 
Six Months Ended June 30,
 
Three Months Ended June 30,
 
2011
 
2010
 
2011
 
2010
REVENUES
 


 
 


 
 
 
 
Net product revenues
$
938,340


 
$


 
$
511,560


 
$


Royalties
1,142,818


 


 
602,818


 


Amortization of deferred revenue
16,984,800


 


 
8,590,874


 


Milestone payment
5,000,000


 


 
5,000,000


 
 
Other revenue
21,984,800


 


 
13,590,874


 


 
 
 
 
 
 
 
 
Total net revenues
$
24,065,958


 
$


 
$
14,705,252


 
$


COST OF PRODUCT REVENUES
 


 
 


 
 
 
 
Cost of product revenues
817,488


 


 
429,355


 


Gross profit
$
23,248,470


 
$


 
$
14,275,897


 
$


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts Receivable
$
6,540,972


 
$


 
 
 
 
The accounts receivable balance at the end of June 30, 2011 included the $5 million milestone payment. The Company has exceeded the cap of $7.0 million by $2.2 million for research and development spending on the PREGNANT Study and related NDA pursuant to the Watson Transactions and has recorded this amount as a reduction of research and development expenses. Watson has paid $1.9 million and has been invoiced for the remaining $0.3 million.